CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety of a Single Dose of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) in Comparison With a Single Dose of SA14-14-2 Vaccine (CD.JEVAX™, Chengdu Institute of Biological Products, China) Administered in Healthy Toddlers in South-Korea

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01396512
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:43.338904+00:00
Published At: 2014-04-25T00:00:00+00:00
Record Updated At: 2014-04-25
Results Posted At: 2014-04-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Japanese Encephalitis", "Japanese Encephalitis Virus Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2014-04-25"
protocolSection.identificationModule.nctId: "NCT01396512"
protocolSection.identificationModule.officialTitle: "Immunogenicity and Safety of a Single Dose of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV\u2122) in Comparison With a Single Dose of SA14-14-2 Vaccine (CD.JEVAX\u2122, Chengdu Institute of Biological Products, China) Administered in Healthy Toddlers in South-Korea"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2014-04-25"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.